• Net sales (4.0)%; organic sales1 (4.2)%
• Diluted EPS was $0.22; adjusted diluted EPS1 was $0.29
• Continues to advance ongoing review of strategic alternatives, while taking actions to accelerate profitable growth under the new executive team
• Revises outlook for FY’25